Key Findings:  Cannabis sativa strains PARIS, DQ, and sCBD, containing cannabidiol (CBC) and tetrahydrocannabinol (THC), exhibit significant anticancer activity against urothelial cancer cell lines and ex vivo model.
Type of Study:  Laboratory Study
Study Result:  Positive
Research Location(s):  Israel, United States
Year of Pub:  2025
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Not Applicable
Citation:  Anis O, Bar V, Zundelevich A, Anil SM, Shav-Tal Y, Toren A, Dominissini D, Raviv G, Laufer M, Lazarovich A, Drori T, Ramon J, Dotan Z, Koltai H. Targeting bladder cancer: Potent anti-cancer effects of cannabichromene and delta-9-tetrahydrocannabinol-rich Cannabis sativa strains. Asian J Urol. 2025 Oct;12(4):534-543. doi: 10.1016/j.ajur.2025.03.004. Epub 2025 Apr 9. PMID: 41467200; PMCID: PMC12744700.